US company trials coronavirus vaccine candidate in Australia
A U.S. biotechnology company began injecting a coronavirus vaccine candidate into people in Australia on Tuesday with hopes of releasing
$5 million supports research into neglected tropical diseases
Researchers at Washington University School of Medicine in St. Louis have received two grants from the National Institutes of Health
